Molecular Interplay between hypertension and dyslipidemia in cardiovascular pathogenesis: toward precision-based therapeutic strategies - Poll - MDSpire

Molecular Interplay between hypertension and dyslipidemia in cardiovascular pathogenesis: toward precision-based therapeutic strategies

  • By

  • Boming Cao

  • Jingyi Pei

  • Ling Kong

  • Ying Han

  • Guangli Yan

  • Xijun Wang

  • June 11, 2026

  • 0 min

Share

Original Source(s)

Molecular Interplay between hypertension and dyslipidemia in cardiovascular pathogenesis: toward precision-based therapeutic strategies

  • by Boming Cao, Jingyi Pei, Ling Kong, Ying Han, Guangli Yan, Xijun Wang

  • June 11, 2026

Related Content

Assessing modifiable risk factors for atrial fibrillation/flutter in the young: a hybrid local-global study

Monitoring Blood Pressure Outside of Your Doctor’s Office

Optimizing Food-Is-Medicine Programs for High Blood Pressure